Non-COVID-19 respiratory viral infection

Cláudio Nunes-Silva; Ana Teresa Vilares; Valentijn Schweitzer; Susana Castanhinha; António Martins; Maria João Lopes; Tommaso Ascoli-Bartoli; Gabriela Canelas; Holly R Keir; Flávia Cunha; André Silva-Pinto; Sandra Rebelo; Rui Guimarães Cunha; Margarida Tavares

doi:10.1183/20734735.0151-2021

Non-COVID-19 respiratory viral infection

Cláudio Nunes-Silva, Ana Teresa Vilares, Valentijn Schweitzer, Susana Castanhinha, António Martins, Maria João Lopes, Tommaso Ascoli-Bartoli, Gabriela Canelas, Holly R Keir, Flávia Cunha, André Silva-Pinto, Sandra Rebelo, Rui Guimarães Cunha, Margarida Tavares^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

2 Downloads (Pure)

Abstract

Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.

Original language	English
Article number	210151
Journal	Breathe
Volume	18
Issue number	1
DOIs	https://doi.org/10.1183/20734735.0151-2021
Publication status	Published - Mar 2022

Access to Document

10.1183/20734735.0151-2021Licence: CC BY-NC

Breathe-2022-Nunes-Silva-210151Final published version, 1.37 MBLicence: CC BY-NC

Cite this

@article{e784ec99896747738c55776c43a4b84f,

title = "Non-COVID-19 respiratory viral infection",

abstract = "Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.",

author = "Cl{\'a}udio Nunes-Silva and Vilares, {Ana Teresa} and Valentijn Schweitzer and Susana Castanhinha and Ant{\'o}nio Martins and Lopes, {Maria Jo{\~a}o} and Tommaso Ascoli-Bartoli and Gabriela Canelas and Keir, {Holly R} and Fl{\'a}via Cunha and Andr{\'e} Silva-Pinto and Sandra Rebelo and Cunha, {Rui Guimar{\~a}es} and Margarida Tavares",

note = "Publisher Copyright: {\textcopyright} ERS 2022.",

year = "2022",

month = mar,

doi = "10.1183/20734735.0151-2021",

language = "English",

volume = "18",

journal = "Breathe",

issn = "1810-6838",

publisher = "European Respiratory Society",

number = "1",

}

TY - JOUR

T1 - Non-COVID-19 respiratory viral infection

AU - Nunes-Silva, Cláudio

AU - Vilares, Ana Teresa

AU - Schweitzer, Valentijn

AU - Castanhinha, Susana

AU - Martins, António

AU - Lopes, Maria João

AU - Ascoli-Bartoli, Tommaso

AU - Canelas, Gabriela

AU - Keir, Holly R

AU - Cunha, Flávia

AU - Silva-Pinto, André

AU - Rebelo, Sandra

AU - Cunha, Rui Guimarães

AU - Tavares, Margarida

PY - 2022/3

Y1 - 2022/3

N2 - Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.

AB - Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.

U2 - 10.1183/20734735.0151-2021

DO - 10.1183/20734735.0151-2021

M3 - Review article

C2 - 36338246

SN - 1810-6838

VL - 18

JO - Breathe

JF - Breathe

IS - 1

M1 - 210151

ER -

Non-COVID-19 respiratory viral infection

Abstract

Access to Document

Fingerprint

Cite this